Monopar Therapeutics Inc.
Monopar Therapeutics Inc. (MNPR) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
mnpr · stock forecast · 13 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 13 Wall Street analysts in the past 3 months
Buy
13 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$115
Consensus
$110
+81.5% upside
Low
$105
Median: $110 · Last Close: $60.61
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$110.00
81.5% upside
High Target
$115
89.7%
Low Target
$105
73.2%
Current Price
$60.61
as of today
Based on analyst price targets, the MNPR stock price prediction for the next 12 months ranges from $105 to $115. The consensus MNPR price forecast of $110.00 implies 81.5% upside from the current price of $60.61.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $59.60 | ↓ 1.66% |
1-day model range: $59.06–$60.15. Peak: $60.15 (-1.66%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $133 | +120.0% |
| 2028 | $221 | +265.2% |
| 2029 | $302 | +397.8% |
| 2030 | $362 | +497.1% |
| 2031 | — | +562.7% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MNPR · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-30 | Chardan Capital | Maintains | Buy→Buy |
| 2026-02-23 | BTIG | Maintains | Buy→Buy |
| 2026-02-02 | BTIG | Maintains | Buy→Buy |
| 2026-01-29 | Chardan Capital | Maintains | Buy→Buy |
| 2026-01-14 | BTIG | Maintains | Buy→Buy |
| 2025-11-14 | Raymond James | Downgrade ↓ | Strong Buy→Outperform |
| 2025-11-13 | Chardan Capital | Maintains | Buy→Buy |
| 2025-11-09 | Chardan Capital | Maintains | Buy→Buy |
| 2025-10-06 | Raymond James | Maintains | Strong Buy→Strong Buy |
| 2025-10-02 | Oppenheimer | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Monopar Therapeutics Inc. (MNPR) stock. Of the recent 38 rating actions, 1 were upgrades and 3 were downgrades. 13 analysts currently cover MNPR.
Analyst Recommendation Trends
MNPR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 99.5% YoY
Revenue Next Year
$15M
↑ 3751.2% YoY
EPS This Year
$-2.66
EPS Next Year
$-3.29
↑ 23.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast MNPR EPS of $-2.66 for the current fiscal year, based on estimates from 9 analysts. The MNPR revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The MNPR stock forecast is supported by two independent data sources: analyst consensus ratings from 13 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MNPR price target is $110.00 (+81.5% upside), with an analyst consensus of Buy.
The MNPR short-term stock prediction for tomorrow is $59.60 (-1.66%). The MNPR stock price prediction for 2027 estimates an average of $133. The MNPR stock prediction for 2030 projects a range of $326–$398.
Monopar Therapeutics Inc. trades on NASDAQ under the ticker MNPR. The MNPR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 85% of covering analysts.
Frequently asked questions
MNPR forecast · 8 questionsAccording to 13 Wall Street analysts, the average 12-month MNPR price target is $110.00, with a high forecast of $115.00 and a low of $105.00. The median price target is shown in the chart above when available. This implies +81.5% potential upside from the current price of $60.61.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.